Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study

BACKGROUND: The rarity of neuroendocrine malignancies limits the ability to develop new therapies and thus a better understanding of the underlying biology is critical. METHODS: Through a prospective, IRB-approved protocol, patients with neuroendocrine malignancies underwent next-generation sequenci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Vijayvergia, Namrata, Boland, Patrick M, Handorf, Elizabeth, Gustafson, Karen S, Gong, Yulan, Cooper, Harry S, Sheriff, Fathima, Astsaturov, Igor, Cohen, Steven J, Engstrom, Paul F
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997552/
https://ncbi.nlm.nih.gov/pubmed/27482646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.229
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados